Viral Vector Manufacturing Services - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB511242211

Publication Date:

November 28, 2024

Pages:

112

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global market for Viral Vector Manufacturing Services was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Viral Vector Manufacturing Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Viral Vector Manufacturing Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Viral Vector Manufacturing Services was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Viral Vector Manufacturing Services include Novasep, Lonza Pharma & Biotech, ABL, Inc., Takara Bio, Sartorius, Cobra Biologics, Finvector, Fujifilm Diosynth Biotechnologies and Sanofi, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Viral Vector Manufacturing Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Viral Vector Manufacturing Services by region & country, by Type, and by Application.
The Viral Vector Manufacturing Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Viral Vector Manufacturing Services.
麻豆原创 Segmentation
By Company
Novasep
Lonza Pharma & Biotech
ABL, Inc.
Takara Bio
Sartorius
Cobra Biologics
Finvector
Fujifilm Diosynth Biotechnologies
Sanofi
Spark Therapeutics
uniQure
Segment by Type:
Retroviral Vectors
Adenoviral Vectors
Adeno-associated Viral Vectors
Other Viral Vectors
Segment by Application
Pharmaceutical and Biopharmaceutical Companies
Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Viral Vector Manufacturing Services manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Viral Vector Manufacturing Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Viral Vector Manufacturing Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Viral Vector Manufacturing Services Product Introduction
1.2 Global Viral Vector Manufacturing Services 麻豆原创 Size Forecast
1.3 Viral Vector Manufacturing Services 麻豆原创 Trends & Drivers
1.3.1 Viral Vector Manufacturing Services Industry Trends
1.3.2 Viral Vector Manufacturing Services 麻豆原创 Drivers & Opportunity
1.3.3 Viral Vector Manufacturing Services 麻豆原创 Challenges
1.3.4 Viral Vector Manufacturing Services 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Viral Vector Manufacturing Services Players Revenue Ranking (2023)
2.2 Global Viral Vector Manufacturing Services Revenue by Company (2019-2024)
2.3 Key Companies Viral Vector Manufacturing Services Manufacturing Base Distribution and Headquarters
2.4 Key Companies Viral Vector Manufacturing Services Product Offered
2.5 Key Companies Time to Begin Mass Production of Viral Vector Manufacturing Services
2.6 Viral Vector Manufacturing Services 麻豆原创 Competitive Analysis
2.6.1 Viral Vector Manufacturing Services 麻豆原创 Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Viral Vector Manufacturing Services Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing Services as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Retroviral Vectors
3.1.2 Adenoviral Vectors
3.1.3 Adeno-associated Viral Vectors
3.1.4 Other Viral Vectors
3.2 Global Viral Vector Manufacturing Services Sales Value by Type
3.2.1 Global Viral Vector Manufacturing Services Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Viral Vector Manufacturing Services Sales Value, by Type (2019-2030)
3.2.3 Global Viral Vector Manufacturing Services Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical and Biopharmaceutical Companies
4.1.2 Research Institutes
4.2 Global Viral Vector Manufacturing Services Sales Value by Application
4.2.1 Global Viral Vector Manufacturing Services Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Viral Vector Manufacturing Services Sales Value, by Application (2019-2030)
4.2.3 Global Viral Vector Manufacturing Services Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Viral Vector Manufacturing Services Sales Value by Region
5.1.1 Global Viral Vector Manufacturing Services Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Viral Vector Manufacturing Services Sales Value by Region (2019-2024)
5.1.3 Global Viral Vector Manufacturing Services Sales Value by Region (2025-2030)
5.1.4 Global Viral Vector Manufacturing Services Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Viral Vector Manufacturing Services Sales Value, 2019-2030
5.2.2 North America Viral Vector Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Viral Vector Manufacturing Services Sales Value, 2019-2030
5.3.2 Europe Viral Vector Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Viral Vector Manufacturing Services Sales Value, 2019-2030
5.4.2 Asia Pacific Viral Vector Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Viral Vector Manufacturing Services Sales Value, 2019-2030
5.5.2 South America Viral Vector Manufacturing Services Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Viral Vector Manufacturing Services Sales Value, 2019-2030
5.6.2 Middle East & Africa Viral Vector Manufacturing Services Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Viral Vector Manufacturing Services Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Viral Vector Manufacturing Services Sales Value
6.3 United States
6.3.1 United States Viral Vector Manufacturing Services Sales Value, 2019-2030
6.3.2 United States Viral Vector Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Viral Vector Manufacturing Services Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Viral Vector Manufacturing Services Sales Value, 2019-2030
6.4.2 Europe Viral Vector Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Viral Vector Manufacturing Services Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Viral Vector Manufacturing Services Sales Value, 2019-2030
6.5.2 China Viral Vector Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.5.3 China Viral Vector Manufacturing Services Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Viral Vector Manufacturing Services Sales Value, 2019-2030
6.6.2 Japan Viral Vector Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Viral Vector Manufacturing Services Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Viral Vector Manufacturing Services Sales Value, 2019-2030
6.7.2 South Korea Viral Vector Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Viral Vector Manufacturing Services Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Viral Vector Manufacturing Services Sales Value, 2019-2030
6.8.2 Southeast Asia Viral Vector Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Viral Vector Manufacturing Services Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Viral Vector Manufacturing Services Sales Value, 2019-2030
6.9.2 India Viral Vector Manufacturing Services Sales Value by Type (%), 2023 VS 2030
6.9.3 India Viral Vector Manufacturing Services Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Novasep
7.1.1 Novasep Profile
7.1.2 Novasep Main Business
7.1.3 Novasep Viral Vector Manufacturing Services Products, Services and Solutions
7.1.4 Novasep Viral Vector Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.1.5 Novasep Recent Developments
7.2 Lonza Pharma & Biotech
7.2.1 Lonza Pharma & Biotech Profile
7.2.2 Lonza Pharma & Biotech Main Business
7.2.3 Lonza Pharma & Biotech Viral Vector Manufacturing Services Products, Services and Solutions
7.2.4 Lonza Pharma & Biotech Viral Vector Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.2.5 Lonza Pharma & Biotech Recent Developments
7.3 ABL, Inc.
7.3.1 ABL, Inc. Profile
7.3.2 ABL, Inc. Main Business
7.3.3 ABL, Inc. Viral Vector Manufacturing Services Products, Services and Solutions
7.3.4 ABL, Inc. Viral Vector Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.3.5 Takara Bio Recent Developments
7.4 Takara Bio
7.4.1 Takara Bio Profile
7.4.2 Takara Bio Main Business
7.4.3 Takara Bio Viral Vector Manufacturing Services Products, Services and Solutions
7.4.4 Takara Bio Viral Vector Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.4.5 Takara Bio Recent Developments
7.5 Sartorius
7.5.1 Sartorius Profile
7.5.2 Sartorius Main Business
7.5.3 Sartorius Viral Vector Manufacturing Services Products, Services and Solutions
7.5.4 Sartorius Viral Vector Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.5.5 Sartorius Recent Developments
7.6 Cobra Biologics
7.6.1 Cobra Biologics Profile
7.6.2 Cobra Biologics Main Business
7.6.3 Cobra Biologics Viral Vector Manufacturing Services Products, Services and Solutions
7.6.4 Cobra Biologics Viral Vector Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.6.5 Cobra Biologics Recent Developments
7.7 Finvector
7.7.1 Finvector Profile
7.7.2 Finvector Main Business
7.7.3 Finvector Viral Vector Manufacturing Services Products, Services and Solutions
7.7.4 Finvector Viral Vector Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.7.5 Finvector Recent Developments
7.8 Fujifilm Diosynth Biotechnologies
7.8.1 Fujifilm Diosynth Biotechnologies Profile
7.8.2 Fujifilm Diosynth Biotechnologies Main Business
7.8.3 Fujifilm Diosynth Biotechnologies Viral Vector Manufacturing Services Products, Services and Solutions
7.8.4 Fujifilm Diosynth Biotechnologies Viral Vector Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.8.5 Fujifilm Diosynth Biotechnologies Recent Developments
7.9 Sanofi
7.9.1 Sanofi Profile
7.9.2 Sanofi Main Business
7.9.3 Sanofi Viral Vector Manufacturing Services Products, Services and Solutions
7.9.4 Sanofi Viral Vector Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.9.5 Sanofi Recent Developments
7.10 Spark Therapeutics
7.10.1 Spark Therapeutics Profile
7.10.2 Spark Therapeutics Main Business
7.10.3 Spark Therapeutics Viral Vector Manufacturing Services Products, Services and Solutions
7.10.4 Spark Therapeutics Viral Vector Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.10.5 Spark Therapeutics Recent Developments
7.11 uniQure
7.11.1 uniQure Profile
7.11.2 uniQure Main Business
7.11.3 uniQure Viral Vector Manufacturing Services Products, Services and Solutions
7.11.4 uniQure Viral Vector Manufacturing Services Revenue (US$ Million) & (2019-2024)
7.11.5 uniQure Recent Developments
8 Industry Chain Analysis
8.1 Viral Vector Manufacturing Services Industrial Chain
8.2 Viral Vector Manufacturing Services Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Viral Vector Manufacturing Services Sales Model
8.5.2 Sales Channel
8.5.3 Viral Vector Manufacturing Services Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Novasep
Lonza Pharma & Biotech
ABL, Inc.
Takara Bio
Sartorius
Cobra Biologics
Finvector
Fujifilm Diosynth Biotechnologies
Sanofi
Spark Therapeutics
uniQure

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.